CONTINUUM OF PROGRESS
Seqens is an integrated global leader in pharmaceutical synthesis and specialty ingredients, delivering outstanding performance, unrivalled market responsiveness and custom-made solutions to our customers.
Our mission is to bring R&D and industrial performance to our clients’ projects with our unique skill set and a broad range of technologies.
Seqens operates 24 industrial plants and 3 R&D centers in Europe, North America and Asia. More than 300 scientists, engineers and other experts develop tailor-made solutions for our customers and ensure that products are successfully transferred into production.
In the pharmaceutical industry, Seqens supports our customers in developing, scaling up and manufacturing drug substances from the pre-clinical phase to the commercial phase. We also offer a large portfolio of APIs and proprietary products.Seqens also develops custom solutions and ingredients for the most demanding industries such as healthcare, electronics, cosmetics, food and household cleaners.
Driven by a culture of excellence and a strong entrepreneurial spirit, the 3,200 employees Seqens are committed to providing our customers with the highest level of service and product quality while acting ethically in alignment with our Corporate Social Responsibility program.
A GLOBAL PLAYER IN PHARMACEUTICAL SYNTHESIS AND SPECIALTY INGREDIENTS
Two main business activities supported by a broad range of cross-functional technologies, R&D expertise and global assets.
